Nayzilam 5 MG nasal sprays
Ended Awarded
- Contract number
- SPE2DB26FDD82
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,482
Award facts
- Contract value 100% obligated
- $4,482.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,482 on October 27, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nayzilam 5 mg nasal sprays. This firm fixed-price delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The award is funded by the Defense Logistics Agency and represents a continuation of the company's substantial federal contracting activity supporting the Department of Defense's pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DB26FDD82?
SPE2DB26FDD82 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDD82 worth?
The government has obligated $4,482 on SPE2DB26FDD82.
Is contract SPE2DB26FDD82 an order under another contract?
Yes. SPE2DB26FDD82 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB26FDD82 competed?
The extent of competition for SPE2DB26FDD82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award